Tag: preclinical
-
Engineered Virus Delivers Brain-Targeted Gene Therapy
Neuroscience researchers designed a process for delivering gene therapies through the blood stream, but targeting only brain cells of lab animals.
-
Covid-19 Antibody Cocktail Trial Request Filed
A discoverer of synthetic antibodies is asking Food and Drug Administration for clearance to begin a clinical trial of a Covid-19 antibody cocktail therapy.
-
Samsung, Biotech Partner on mRNA Vaccine Production
A developer of synthetic RNA products is partnering with Samsung Biologics to manufacture Covid-19 vaccines made with messenger RNA.
-
Small Biz Grant Funds Long-Term Spasticity Implant
A developer of treatments for neurological disorders received National Institutes of Health funding for an implant treating spasticity for up to six months.
-
Targeted Immunotherapy Shown to Shrink, Stop Tumors
Results from tests with lab mice show an experimental targeted cancer therapy invoking the immune system shrinks tumors and prevents their recurrence.
-
Chip Device Simulates Coronavirus Gut Symptoms
Biomedical engineers found a chip device with intestinal tissue can simulate coronavirus infections and symptoms in the gut, and test possible treatments.
-
Cell Therapy Biotech Raises $75.5M in Venture Funds
A developer of off-the-shelf genetically engineered platelet cells to treat a range of diseases is raising $75.5 million in its second venture round.
-
Hydrogel Obesity Capsule Shown to Protect Gut Tissue
Lab tests show an ingestible hydrogel designed to encourage weight loss by acting like raw vegetables helps protect and regulate intestinal tissue.
-
Stem Cell Patch Shown to Repair Retinal Damage
Research with lab rats shows a transplanted tissue patch derived from stem cells repairs damaged retinas and helps restore visual functions.
-
Biotech Gains $1M for Gut-Brain Pain Research
A biotechnology company developing treatments in the gut for mental health disorders is receiving a $1 million award for research on pain.